29 related articles for article (PubMed ID: 34915638)
1. Association Between a History of Breast Cancer and Decreased Thyroid Cancer-specific Mortality.
Lin S; Wang Z; Xing M
J Clin Endocrinol Metab; 2024 Apr; 109(5):1222-1230. PubMed ID: 38064679
[TBL] [Abstract][Full Text] [Related]
2. Thyroid Hormone Changes Correlate to Combined Breast Cancer with Primary Thyroid Cancer.
Jin J; Li J; Liu Y; Shi Q; Zhang B; Ji Y; Hu P
Breast Cancer (Dove Med Press); 2024; 16():15-22. PubMed ID: 38223235
[TBL] [Abstract][Full Text] [Related]
3. Survival Outcomes in Thyroid Cancer Patients with Co-Occurring Breast Cancer: Evidence of Mortality Risk Attenuation.
Baumgarten MW; Goemann IM; Scheffel RS; Maia AL
Clin Breast Cancer; 2024 Apr; ():. PubMed ID: 38670860
[TBL] [Abstract][Full Text] [Related]
4. Impact of Pregnancy on Breast Cancer Features and Prognosis.
Bounous VE; Minella C; Fuso L; Actis S; Petroni G; Sgrò LG; Borghese M; Tomasi Cont N; Ponzone R; Ferrero A
Curr Oncol; 2024 Apr; 31(4):2305-2315. PubMed ID: 38668074
[TBL] [Abstract][Full Text] [Related]
5. Time Intervals between Double Primary Breast and Ovarian Cancers and Survival Outcomes of Patients with Both Cancers: A SEER Database Analysis.
He XQ; Gao YT; Zhang X; Jiang H
Biomed Res Int; 2022; 2022():4557346. PubMed ID: 35707375
[TBL] [Abstract][Full Text] [Related]
6. Risk of first recurrence after treatment in a population-based cohort of young women with breast cancer.
Schaffar R; Benhamou S; Chappuis PO; Rapiti E
Breast Cancer Res Treat; 2024 Apr; ():. PubMed ID: 38687430
[TBL] [Abstract][Full Text] [Related]
7. Double versus Single Primary Malignant Neoplasm of Breast and Colorectal Cancer: A Case-Control Study.
Tantiphlachiva K; Junprakhon P; Saetun S; Manasnayakorn S; Vongsaisuwan M; Vongwattanakit P; Vacharathit V
Asian Pac J Cancer Prev; 2024 Jan; 25(1):219-227. PubMed ID: 38285787
[TBL] [Abstract][Full Text] [Related]
8. Application of additive hazards models for analyzing survival of breast cancer patients.
Ataee Dizaji P; Vasheghani Farahani M; Sheikhaliyan A; Biglarian A
J Res Med Sci; 2020; 25():99. PubMed ID: 33273944
[TBL] [Abstract][Full Text] [Related]
9. Characteristics and survival analysis of breast cancer survivors with metachronous double primary cancers: a retrospective cohort study.
Song Y; Wang J; Wang X; Li R; Niu X; Yang Y; Yang X; Yin L; Wang Y; Zhang H; Shui R; Zhang C; An J
Transl Cancer Res; 2023 Apr; 12(4):939-948. PubMed ID: 37180649
[TBL] [Abstract][Full Text] [Related]
10. Risk Factors of Synchronous Breast and Thyroid Cancer: a Controlled Multicenter Study and Review of the Literature.
Zervoudis S; Iatrakis G; Markja A; Tsatsaris G; Bothou A; von Tempelhoff GF; Balafouta M; Tsikouras P
Mater Sociomed; 2021 Dec; 33(4):298-303. PubMed ID: 35210954
[TBL] [Abstract][Full Text] [Related]
11. Thyroid Metastasis from Primary Breast Cancer.
Patrizio A; Ferrari SM; Stoppini G; Palmisano E; Elia G; Ragusa F; Paparo SR; Balestri E; Mazzi V; Botrini C; Proietti A; Famà F; Benvenga S; Antonelli A; Fallahi P
J Clin Med; 2023 Apr; 12(7):. PubMed ID: 37048792
[TBL] [Abstract][Full Text] [Related]
12. [Clinical characteristics and prognostic analysis of double primary breast cancer and thyroid cancer].
Zhai J; Kong XY; Fang Y; Wang J
Zhonghua Zhong Liu Za Zhi; 2021 Dec; 43(12):1287-1291. PubMed ID: 34915638
[No Abstract] [Full Text] [Related]
13. Increased expression of thyroid hormone receptor alpha and estrogen receptor alpha in breast cancer associated with thyroid cancer.
Kim YA; Kim YA; Cho SW; Song YS; Min HS; Park IA; Park DJ; Hwang KT; Park YJ
Eur J Surg Oncol; 2021 Jun; 47(6):1316-1323. PubMed ID: 33558123
[TBL] [Abstract][Full Text] [Related]
14. Characteristics and survival of patients with metachronous or synchronous double primary malignancies: breast and thyroid cancer.
Zhang L; Wu Y; Liu F; Fu L; Tong Z
Oncotarget; 2016 Aug; 7(32):52450-52459. PubMed ID: 27223440
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer prognosis is better in patients who develop subsequent metachronous thyroid cancer.
Lei K; He X; Yu L; Ni C; Chen H; Guan D; Sun K; Zou H
PLoS One; 2019; 14(5):e0215948. PubMed ID: 31042767
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
